Cargando…

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R

Neuroblast differentiation-associated protein AHNAK, a large structural scaffold protein, remains mysterious in biological processes. AHNAK plays a suppressive or progressive role in different types of cancers. To investigate the role of the AHNAK in hepatocellular carcinoma (HCC), cell viability as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kang, Song, Ke, Hou, Yuli, Tian, Yuan, Wang, Huijuan, Sun, Libo, Li, Ang, Zhang, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782793/ https://www.ncbi.nlm.nih.gov/pubmed/36557813 http://dx.doi.org/10.3390/molecules27248680

Ejemplares similares

Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV‐related liver diseases
por: Sun, Libo, et al.
Publicado: (2018)

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
por: Peng, Rui, et al.
Publicado: (2019)

AHNAKs roles in physiology and malignant tumors
por: Zhang, Shusen, et al.
Publicado: (2023)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas: AHNAK2 is a biomarker for adenocarcinomas
por: Xu, Meng, et al.
Publicado: (2022)

Diagnostic and prognostic value of STAP1 and AHNAK methylation in peripheral blood immune cells for HBV-related hepatopathy
por: Sun, Libo, et al.
Publicado: (2023)

Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release
por: Zacharias, Ute, et al.
Publicado: (2011)

AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2
por: Xie, Meng, et al.
Publicado: (2022)

Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1
por: Li, Xin, et al.
Publicado: (2023)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

CircRNA_0008194 functions as a ceRNA to promote invasion of hepatocellular carcinoma via inhibiting miR‐190a/AHNAK signaling pathway
por: Liu, Wei, et al.
Publicado: (2022)

Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
por: Xie, Zhenyu, et al.
Publicado: (2020)

AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture
por: Benaud, Christelle, et al.
Publicado: (2004)

MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R
por: Ren, Liang, et al.
Publicado: (2019)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition
por: Sohn, Mira, et al.
Publicado: (2018)

Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK
por: Xiang, Xiao, et al.
Publicado: (2021)

Identification and Functional Validation of Radioresistance-Related Genes AHNAK2 and EVPL in Esophageal Squamous Cell Carcinoma by Exome and Transcriptome Sequencing Analyses
por: Hou, Qiang, et al.
Publicado: (2021)

Protein kinase B phosphorylates AHNAK and regulates its subcellular localization
por: Sussman, Joshua, et al.
Publicado: (2001)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
por: Koguchi, Dai, et al.
Publicado: (2021)

AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
por: Wang, Minglei, et al.
Publicado: (2017)

The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
por: Ngo, Mai-Huong Thi, et al.
Publicado: (2021)

Genetic Polymorphisms of IGF1 and IGF1R Genes and Their Effects on Growth Traits in Hulun Buir Sheep
por: Ding, Ning, et al.
Publicado: (2022)

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2017)

The human gene AHNAK encodes a large phosphoprotein located primarily in the nucleus
Publicado: (1993)

Interferon-Induced Transmembrane Protein 3 Expression Upregulation Is Involved in Progression of Hepatocellular Carcinoma
por: Hou, Yuli, et al.
Publicado: (2021)

AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility
por: Silva, Thaiomara A., et al.
Publicado: (2016)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma
por: Wang, Dong-Wei, et al.
Publicado: (2020)

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway
por: Cai, Yanlin, et al.
Publicado: (2021)

Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway
por: Yang, Insook, et al.
Publicado: (2022)

Ahnak is required to balance calcium ion homeostasis and smooth muscle development in the urinary system
por: Lee, Jong-Min, et al.
Publicado: (2023)

Lactoferrin Induces Osteoblast Growth through IGF-1R
por: Hou, Jian-Ming, et al.
Publicado: (2015)

Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma
por: Hou, Yuli, et al.
Publicado: (2019)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells
por: LI, XIAOYIN, et al.
Publicado: (2023)

Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway
por: Lee, I H, et al.
Publicado: (2014)

AHNAK deficiency promotes browning and lipolysis in mice via increased responsiveness to β-adrenergic signalling
por: Shin, Jae Hoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_en9mi4kpqr0ddtc1uv38a5lqtq